1. Home
  2. CREG vs ITRM Comparison

CREG vs ITRM Comparison

Compare CREG & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CREG

Smart Powerr Corp.

N/A

Current Price

$1.20

Market Cap

27.1M

Sector

Utilities

ML Signal

N/A

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.33

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CREG
ITRM
Founded
N/A
2015
Country
China
Ireland
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.1M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CREG
ITRM
Price
$1.20
$0.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
87.0K
918.4K
Earning Date
02-14-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$173,659.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$193.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$0.26
52 Week High
$14.70
$1.75

Technical Indicators

Market Signals
Indicator
CREG
ITRM
Relative Strength Index (RSI) 45.13 45.27
Support Level $1.16 $0.31
Resistance Level $1.34 $0.39
Average True Range (ATR) 0.12 0.03
MACD -0.02 0.01
Stochastic Oscillator 19.34 32.08

Price Performance

Historical Comparison
CREG
ITRM

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: